Dosimetry Associated with Veterans who Participated in Nuclear Weapons Testing.

This article summarizes the methodology, results, and challenges of the reconstruction of red bone marrow and male breast doses for a 1,982-person sub-cohort of ∼114,270 U.S. military veterans who participated in eight atmospheric nuclear weapons tests between 1945 and 1962. These doses are being used in an epidemiological investigation of leukemia and male breast cancer as part of a study of one million U.S. persons to investigate risk from chronic low-dose radiation exposure. METHODS: Previous doses to these veterans had been estimated for compensation and tended to be biased high but newly available documentation made calculating individual doses and uncertainties using detailed exposure scenarios for each veteran possible. The techniques outlined in this report detail the methodology for developing individual scenarios and accounting for bias and uncertainty in dose based on the assumptions made about exposure. RESULTS: Doses to the atomic veterans in this sub-cohort were relatively low, with about two-thirds receiving red bone marrow doses <5 mGy and only four individuals receiving a red bone marrow dose >50 mGy. The average red bone marrow dose for members of the sub-cohort was 5.9 mGy. Doses to male breast were approximately 20% higher than red bone marrow doses. Discussion and Challenges: Relatively low uncertainty was achieved as a result of our methodology for reconstructing exposures based on knowledge of the individual veterans' locations...
Source: International Journal of Radiation Biology - Category: Radiology Tags: Int J Radiat Biol Source Type: research